Blair William & Co
- SEC CIK
- 0000902367
- Latest filing
- Aug 11, 2026
PHAS holding history
PhaseBio Pharmaceuticals Inc in every 13F filed by Blair William & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PHAS overviewAll 13F holders of PHASFull Q2 2026 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −35,696−100.0% | Sold out | Holders |
| Q3 2022 | 35,696 | $6.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 35,696 | $21.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 35,696 | $47.0K | <0.1% | +12,810+56.0% | Added | Holders |
| Q4 2021 | 22,886 | $60.0K | <0.1% | +4,886+27.1% | Added | Holders |
| Q3 2021 | 18,000 | $56.0K | <0.1% | +1,000+5.9% | Added | Holders |
| Q2 2021 | 17,000 | $63.0K | <0.1% | −89,500−84.0% | Reduced | Holders |
| Q1 2021 | 106,500 | $368.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.